Sep 27, 2023 / 07:35PM GMT
Unidentified Analyst -
Hi. Good afternoon, everyone. Welcome to the Cantor Conference. I wanted to introduce Dean Schorno, who's the CFO of Rigel. Thanks so much for being at our conference.
Dean L. Schorno - Rigel Pharmaceuticals, Inc. - Executive VP & CFO
Well, thanks, Kristen, for having us and the entire Cantor team for inviting us to your conference. And thanks to all of you for being here today and showing your interest in Rigel.
So as I get started today, I'll be making some forward-looking statements. And just to remind you, I encourage you to take a look at our investor site at rigel.com, for more detail about the company, our corporate presentation deck as well as our SEC filings for more detail.
So I'm really excited today to be here to talk about our hematology oncology-focused business. It's really an exciting time for Rigel. And there's a variety of ways that we look to grow the business, and it's exciting times to grow the business.
Today, I'll talk about a couple of paths forward with respect to that growth. Our
Rigel Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot